Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Innate DNA sensors represent a specialized class of pattern recognition receptors (PRRs) responsible for detecting double-stranded DNA (dsDNA) in inappropriate cellular compartments, such as the cytosol or endosomes. This group includes key proteins like cyclic GMP-AMP synthase (cGAS), Toll-like receptor 9 (TLR9), and Absent in melanoma 2 (AIM2), which serve as the first line of defense against viral and bacterial infections (Source: PubMed, PMID: 30635666). Upon DNA binding, these sensors activate downstream signaling pathways, primarily the cGAS-STING axis, to induce the expression of Type I interferons and other pro-inflammatory cytokines (Source: Nature Reviews Immunology, 2020). Beyond infection, these sensors play a critical role in detecting self-DNA released during cell death or cellular stress, which can drive autoimmune conditions like systemic lupus erythematosus (SLE) if left unchecked (Source: UniProt). In the context of oncology, therapeutic strategies focus on activating these sensors to turn cold tumors hot by recruiting and activating T cells within the tumor microenvironment (Source: NIH, ClinicalTrials.gov). Conversely, small molecule inhibitors targeting cGAS or STING are under investigation for treating autoinflammatory and neurodegenerative diseases (Source: PubMed, PMID: 32433310). The diversity of these sensors allows the immune system to respond to various DNA sources, including mitochondrial DNA and retrotransposons (Source: Nature, 2013).
Agonism of endosomal or cytosolic sensors to stimulate innate immunity and interferon production; Antagonism to inhibit pathological inflammatory signaling.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate DNA sensors.